Svetlana Bajalica Lagercrantz

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Svetlana Bajalica Lagercrantz är adjungerad professor i cancergenetik,
särskilt ärftlig cancer.
Läs mer om hennes forskning (på engelska) [1]
[1] https://ki.se/en/onkpat/research-team-svetlana-bajalica-lagercrantz

Artiklar

Article: BIOMEDICINES. 2022;10(5):1004

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer

Liu Y; Helgadottir HT; Kharaziha P; Choi J; Lopez-Giraldez F; Mane SM; Hoiom V; Juhlin CC; Larsson C; Bajalica-Lagercrantz S
Article: NATURE CANCER. 2022;3(2):251-261

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

Tamborero D; Dienstmann R; Rachid MH; Boekel J; Lopez-Fernandez A; Jonsson M; Razzak A; Brana I; De Petris L; Yachnin J; Baird RD; Loriot Y; Massard C; Martin-Romano P; Opdam F; Schlenk RF; Vernieri C; Masucci M; Villalobos X; Chavarria E; Balmana J; Apolone G; Caldas C; Bergh J; Ernberg I; Frohling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtio J
Article: CANCERS. 2022;14(2):380

Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)

Omran M; Tham E; Brandberg Y; Ahlstrom H; Lundgren C; Paulsson-Karlsson Y; Kuchinskaya E; Silander G; Rosen A; Persson F; Leonhardt H; Stenmark-Askmalm M; Berg J; van Westen D; Bajalica-Lagercrantz S; Blomqvist L
Article: EUROPEAN JOURNAL OF MEDICAL GENETICS. 2021;64(12):104350

Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe

Marmolejo DH; Wong MYZ; Bajalica-Lagercrantz S; Tischkowitz M; Balmana J
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(12):6345

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer

Liu Y; Axell O; van Leeuwen T; Konrat R; Kharaziha P; Larsson C; Wright APH; Bajalica-Lagercrantz S
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(10):1379-1386

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.

Frebourg T; Bajalica Lagercrantz S; Oliveira C; Magenheim R; Evans DG; European Reference Network GENTURIS
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(10):1387-1393

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome.

Tischkowitz M; Colas C; Pouwels S; Hoogerbrugge N; PHTS Guideline Development Group; European Reference Network GENTURIS
Article: HEREDITARY CANCER IN CLINICAL PRACTICE. 2020;18(1):1

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants-the Swedish constitutional TP53 study SWEP53

Omran M; Blomqvist L; Brandberg Y; Pal N; Kogner P; Stahlbom AK; Tham E; Bajalica-Lagercrantz S
Article: CLINICAL GENETICS. 2019;96(3):216-225

Functional characterization of novel germline TP53 variants in Swedish families

Kharaziha P; Ceder S; Axell O; Krall M; Fotouhi O; Bohm S; Lain S; Borg A; Larsson C; Wiman KG; Tham E; Bajalica-Lagercrantz S
Article: FAMILIAL CANCER. 2019;18(2):281-284

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

Vos JR; Giepmans L; Roehl C; Geverink N; Hoogerbrugge N; Ligtenberg M; Kets M; Sijmons R; Evans G; Woodward E; Tischkowitz M; Maher E; Steinke-Lange V; Holinski-Feder E; Frebourg T; Houdayer C; Ferner RE; Lubinski J; Ertmanska K; Bajalica Lagercrantz S; Tham E; Guillermo IB; Capella G; Vidal JB; Lazaro C; Balmana J; Bours V; Legius E; Wolkenstein P; Melegh B; Oliveira C; Teixeira M; Poppe B; Claes K; Hernandez HS; Aretz S; Spier I; Oostenbrink R; Krajc M; Blatnik A; Schrock E; Peltonen S; Hietala M
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;144(5):1195-1204

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Li J; Wen WX; Eklund M; Kvist A; Eriksson M; Christensen HN; Torstensson A; Bajalica-Lagercrantz S; Dunning AM; Decker B; Allen J; Luccarini C; Pooley K; Simard J; Dorling L; Easton DF; Teo S-H; Hall P; Borg A; Gronberg H; Czene K
Article: PATHOBIOLOGY. 2018;85(4):211-219

Proteomic Profiling of Diffuse Large B-Cell Lymphomas

Kwiecinska A; Porwit A; Souchelnytskyi N; Kaufeldt A; Larsson C; Bajalica-Lagercrantz S; Souchelnytskyi S
Article: ONCOTARGET. 2016;7(24):35703-35723

Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells

Pellegrini P; Dyczynski M; Sbrana FV; Karlgren M; Buoncervello M; Hagg-Olofsson M; Ma R; Hartman J; Bajalica-Lagercrantz S; Grander D; Kharaziha P; De Milito A
Article: JOURNAL OF OVARIAN RESEARCH. 2016;9(1):27

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer

Fransson A; Glaessgen D; Alfredsson J; Wiman KG; Bajalica-Lagercrantz S; Mohell N
Article: ONCOTARGET. 2015;6(34):36894-36902

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration

Zhou X; Zhang J; Yun H; Shi R; Wang Y; Wang W; Lagercrantz SB; Mu K
Article: ANNALS OF DIAGNOSTIC PATHOLOGY. 2015;19(4):243-248

A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer

Mu K; Li L; Yang Q; Yun H; Kharaziha P; Ye D-W; Auer G; Lagercrantz SB; Zetterberg A
Article: LANCET. 2015;386(9992):433-443

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Gnant M; Pfeiler G; Dubsky PC; Hubalek M; Greil R; Jakesz R; Wette V; Balic M; Haslbauer F; Melbinger E; Bjelic-Radisic V; Artner-Matuschek S; Fitzal F; Marth C; Sevelda P; Mlineritsch B; Steger GG; Manfreda D; Exner R; Egle D; Bergh J; Kainberger F; Talbot S; Warner D; Fesl C; Singer CF
Article: GENES CHROMOSOMES & CANCER. 2014;53(9):750-768

Amplification of 2p as a Genomic Marker for Transformation in Lymphoma

Kwiecinska A; Ichimura K; Berglund M; Dinets A; Sulaiman L; Collins VP; Larsson C; Porwit A; Lagercrantz SB
Article: PLOS ONE. 2014;9(11):e111125

Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma

Xu L-D; Muller S; Thoppe SR; Hellborg F; Kanter L; Lerner M; Zheng B; Lagercrantz SB; Grander D; Wallin KL; Wiman KG; Larsson C; Andersson S
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(5):1190-1195

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

DaneshManesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Article: LEUKEMIA & LYMPHOMA. 2008;49(3):477-487

Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia

Thelander EF; Ichimura K; Corcoran M; Barbany G; Nordgren A; Heyman M; Berglund M; Mungall A; Rosenquist R; Collins VP; Grander D; Larsson C; Lagercrantz S
Article: LEUKEMIA RESEARCH. 2007;31(9):1219-1230

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma

Thelander EF; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
Article: MODERN PATHOLOGY. 2007;20(1):63-75

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma

Berglund M; Enblad G; Thunberg U; Amini R-M; Sundstrom C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Article: INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. 2006;82(2):87-96

Evaluation of spectral karyotyping (SKY) in biodosimetry for the triage situation following gamma irradiation

Szeles A; Joussineau S; Lewensohn R; Lagercrantz S; Larsson C
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(3):555-563

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma

Sambade C; Berglund M; Lagercrantz S; Sällström JS; Reis RM; Enblad G; Glimelius B; Sundström C
Article: MODERN PATHOLOGY. 2005;18(3):331-339

Mantle cell lymphomas with clonal immunoglobulin V_H3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V_H genes

Thelander EF; Walsh SH; Thorsélius M; Laurell A; Landgren O; Larsson C; Rosenquist R; Lagercrantz S
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2005;26(1):141-149

Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors

Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(4):955-960

Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers

Alimov A; Sundelin B; Bergerheim U; Pavlenko M; Pisa P; Zetterberg A; Larsson C; Lagercrantz S
Article: GENES CHROMOSOMES & CANCER. 2004;41(2):133-144

Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13-24 as an early and common genetic event

Siwicki JK; Berglund M; Rygier J; Pienkowska-Grela B; Grygalewicz B; Degerman S; Golovleva I; Chrzanowska KH; Lagercrantz S; Blennow E; Roos G; Larsson C
Article: CANCER GENETICS. 2003;141(1):43-48

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma

Berglund M; Flordal E; Gullander J; Lui WO; Larsson C; Lagercrantz S; Enblad G
Article: BIOCHEMICAL PHARMACOLOGY. 2003;65(2):237-247

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance

Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Article: CANCER GENETICS. 2002;139(1):38-43

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization

Flordal E; Berglund M; Rosenquist R; Erlanson M; Enblad G; Roos G; Larsson C; Lagercrantz S
Article: LEUKEMIA & LYMPHOMA. 2002;43(11):2179-2189

A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma

Amini RM; Berglund M; Rosenquist R; Von Heideman A; Lagercrantz S; Thunberg U; Bergh J; Sundström C; Glimelius B; Enblad G
Article: MODERN PATHOLOGY. 2002;15(8):807-816

Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization

Berglund M; Enblad G; Flordal E; Lui WO; Backlin C; Thunberg U; Sundström C; Roos G; Allander SV; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2002;20(6):1161-1165

Aberrations of centrosomes in adrenocortical tumors

Roshani L; Fujioka K; Auer G; Kjellman M; Lagercrantz S; Larsson C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2001;8(6):681-689

Differential expression of multiple alternative spliceforms of the Men1 tumor suppressor gene in mouse

Forsberg L; Zablewska B; Piehl F; Weber G; Lagercrantz S; Gaudray P; Höög C; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2001;145(4):415-420

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism

Forsberg L; Villablanca A; Välimäki S; Farnebo F; Farnebo LO; Lagercrantz S; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2001;32(1):43-49

Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma

Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;5(5):485-492

New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding

Nordgren A; Sorensen AG; Tinggaard-Pedersen N; Blennow E; Larsson C; Lagercrantz S
Article: MAMMALIAN GENOME. 1999;10(4):376-380

Characterization and chromosomal localization of the human insulin-like growth factor binding protein 6 gene

Ehrenborg E; Zazzi H; Lagercrantz S; Granqvist M; Hillerbrand U; Allander SV; Larsson C; Luthman H
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1998;247(2):357-360

Expression of the BCL6 gene in the pre- and postnatal mouse

Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Article: GENOMICS. 1998;50(2):275-280

Cloning, expression pattern, and chromosomal assignment to 16q23 of the human gamma-adaptin gene (ADTG).

Peyrard M; Parveneh S; Lagercrantz S; Ekman M; Fransson I; Sahlén S; Dumanski JP
Article: MAMMALIAN GENOME. 1998;9(4):310-311

Mapping of the human Ca²⁺ channel β₄ subunit to 2q22-23 and its expression in developing mouse

Betz R; Leibiger B; Farnebo F; Lagercrantz S; Piehl F; Leibiger I; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(12):4258-4265

Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern

Enmark E; Pelto-Huikko M; Grandien K; Lagercrantz S; Lagercrantz J; Fried G; Nordenskjöld M; Gustafsson J
Article: GENOMICS. 1997;46(1):78-85

Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34

Ernstsson S; Betz R; Lagercrantz S; Larsson C; Ericksson S; Cederberg A; Carlsson P; Enerback S
Article: GENOMICS. 1997;44(3):344-346

Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene

Cederberg A; Betz R; Lagercrantz S; Larsson C; Hulander M; Carlsson P; Enerback S
Article: LEUKEMIA. 1997;11(4):594-598

Expression of LAZ3/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomas

BajalicaLagercrantz S; Piehl F; Lagercrantz J; Lindahl J; Weber G; Kerckeart JP; PorwitMacDonald A; Nordenskjold M
Article: GENOMICS. 1996;38(3):450-451

Localization of the human deoxyguanosine kinase gene (DGUOK) to chromosome 2p13

Johansson M; BajalicaLagercrantz S; Lagercrantz J; Karlsson A
Article: GENOMICS. 1996;36(3):424-430

Primary structure of human 11-cis retinol dehydrogenase and organization and chromosomal localization of the corresponding gene

Simon A; Lagercrantz J; BajalicaLagercrantz S; Eriksson U
Article: CANCER GENETICS. 1996;90(2):102-105

Duplication of 2q31-qter as a sole aberration in a case of non-Hodgkin's lymphoma

BajalicaLagercrantz S; Pedersen NT; Sorensen AG; Nordenskjold M
Article: CHROMOSOME RESEARCH. 1996;4(4):310-313

Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization

Szeles A; BajalicaLagercrantz S; Lindblom A; Lushnikova T; Kashuba VI; Imreh S; Nordenskjold M; Klein G; Zabarovsky ER
Article: IUBMB LIFE. 1996;39(2):303-306

Nucleotide sequence of a cDNA clone (SUBT1) partly homologous to a human subtelomeric repeat sequence.

Lagercrantz J; Lagercrantz S
Article: GENOMICS. 1996;32(3):455-457

The gene for human glutaredoxin (GLRX) is localized to human chromosome 5q14

Padilla CA; Bajalica S; Lagercrantz J; Holmgren A
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1996;218(2):514-517

Chromosomal localization and 5' sequence of the human protein serine threonine phosphatase 5' gene

Xu XL; Lagercrantz J; Zickert P; BajalicaLagercrantz S; Zetterberg A
Article: GENES CHROMOSOMES & CANCER. 1995;13(1):34-39

CHARACTERIZATION OF ADD(I)(P36) IN NON-HODGKIN LYMPHOMAS BY FLUORESCENCE IN-SITU HYBRIDIZATION

BAJALICA S; BRONDUMNIELSEN K; SORENSEN AG; PEDERSEN NT; KRISTOFFERSSON U; AKERMAN M; ANDERSON M; PISA P; NORDENSKJOLD M
Visa fler

Alla övriga publikationer

Review: CANCERS. 2022;14(19):4665

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies

Altena R; Bajalica-Lagercrantz S; Papakonstantinou A
Corrigendum: NATURE CANCER. 2022;3(5):649

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (vol 3, pg 251, 2022)

Tamborero D; Dienstmann R; Rachid MH; Boekel J; Lopez-Fernandez A; Jonsson M; Razzak A; Brana I; De Petris L; Yachnin J; Baird RD; Loriot Y; Massard C; Martin-Romano P; Opdam F; Schlenk RF; Vernieri C; Masucci M; Villalobos X; Chavarria E; Balmana J; Apolone G; Caldas C; Bergh J; Ernberg I; Frohling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtio J
Review: CANCERS. 2020;12(12):E3762-3762

Germline TP53 Testing in Breast Cancers: Why, When and How?

Evans DG; Woodward ER; Bajalica-Lagercrantz S; Oliveira C; Frebourg T
Letter: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(11):1483-1485

Reply to Kratz et al.

Frebourg T; Lagercrantz SB; Oliveira C; Magenheim R; Evans DG; European Reference Network GENTURIS
Letter: NATURE MEDICINE. 2020;26(7):992-994

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

Tamborero D; Dienstmann R; Rachid MH; Boekel J; Baird R; Brana I; De Petris L; Yachnin J; Massard C; Opdam FL; Schlenk R; Vernieri C; Garralda E; Masucci M; Villalobos X; Chavarria E; Calvo F; Frohling S; Eggermont A; Apolone G; Voest EE; Caldas C; Tabernero J; Ernberg I; Rodon J; Lehtio J
Letter: LEUKEMIA & LYMPHOMA. 2007;48(5):1038-1041

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

Berglund M; Thunberg U; Fridberg M; Wingren AG; Gullbo J; Leuchowius K-J; Amini R-M; Lagercrantz S; Horvat A; Enblad G; Soderberg O
Other: JOURNAL OF MEDICAL GENETICS. 1995;32(12):987-990

Partial disomy of Xp and the presence of SRY in a phenotypic female.

Bajalica S; Blennow E; Tşezou A; Galla-Voumvouraki A; Alevizaki M; Sinaniotis C; Kitsiou-Tzeli S

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI